# Attribution of Toxicities Due to Radiotherapy and Immuno-Biological Therapies

> **NCT04115267** · — · RECRUITING · sponsor: **Centre hospitalier de l'Université de Montréal (CHUM)** · enrollment: 3600 (estimated)

## Conditions studied

- Cancer
- Radiotherapy Side Effect

## Interventions

- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT04115267
- **Lead sponsor:** Centre hospitalier de l'Université de Montréal (CHUM)
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-09-13
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-09-30
- **Target enrollment:** 3600 (ESTIMATED)
- **Last updated:** 2024-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04115267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04115267, "Attribution of Toxicities Due to Radiotherapy and Immuno-Biological Therapies". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04115267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*